Efficacy of tamoxifen as the primary treatment of operable breast cancer in the high risk patient.
An audit of 43 breast cancer patients, considered to be of high operative risk and treated only with Tamoxifen was performed. All cases were potentially operable. Good outcome was obtained in only one-third of patients. Salvage surgery had no operative mortality.